LivaNova Board Appoints J. Christopher Barry as New Director
October 06 2023 - 8:30AM
Business Wire
Long-time Director Andrea Saia to retire from
the Board
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology
company, announced its Board of Directors has appointed J.
Christopher Barry to the Board, effective today. Barry will serve
on the Audit and Compliance Committee. Andrea Saia, who has served
as a Director since 2016, will retire from the LivaNova Board on
December 31, 2023.
“The LivaNova Board of Directors is pleased to welcome Chris
Barry,” said Bill Kozy, Interim Chief Executive Officer and Board
Chair of LivaNova. “Chris has spent his career in the medical
technology industry, and we look forward to adding his commercial
expertise and ability to drive long-term growth to the Board.
Additionally, on behalf of the entire Board, I’d like to thank
Andrea for her many contributions, notably her ability to offer
frequent insights on talent, share marketing expertise and her
overall positivity brought clear value to our Board.”
With more than two decades of experience in the medical
technology industry, Barry most recently served as the Chief
Executive Officer and Director of NuVasive, Inc., from November
2018 until its merger with Globus Medical, Inc. in September 2023.
Prior to that, Barry served as Senior Vice President and President
of Surgical Innovations for Medtronic plc, from January 2015 to
October 2018. Previously, Barry spent 15 years with Covidien plc,
in various sales and leadership roles, most recently as President,
Advanced Surgical Technologies, from October 2013 to January 2015.
Barry holds a Bachelor of Science degree in Environmental Science
from Texas Tech University.
“I am honored to join the LivaNova Board of Directors and look
forward to supporting the efforts to bring life-changing
improvements to patients around the world, while maximizing value
to the shareholders,” said Barry.
With these changes, the LivaNova Board will be comprised of 10
Directors until Saia’s retirement at the end of the year.
About LivaNova
LivaNova PLC is a global medical technology company built on
nearly five decades of experience and a relentless commitment to
provide hope for patients and their families through medical
technologies, delivering life-changing improvements for both the
Head and Heart. Headquartered in London, LivaNova employs
approximately 2,900 employees and has a presence in more than 100
countries for the benefit of patients, healthcare professionals and
healthcare systems worldwide. For more information, please visit
www.livanova.com.
Safe Harbor Statement
This news release contains “forward-looking statements”
concerning the Company’s goals, beliefs, expectations, strategies,
objectives, plans and underlying assumptions and other statements
that are not necessarily based on historical facts. These
statements include, but are not limited to, statements regarding
the composition of the Board of Directors. Actual events may differ
materially from those indicated in our forward-looking statements
as a result of various factors, including those factors set forth
in Item 1A of the Company’s most recent Annual Report on Form 10-K,
as supplemented by any risk factors contained in Quarterly Reports
on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes
no obligation to update the information contained in this press
release to reflect subsequently occurring events or
circumstances.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231006861584/en/
LivaNova Investor Relations and Media Contacts
+1 281-895-2382 Briana Gotlin Director, Investor
Relations InvestorRelations@livanova.com
Deanna Wilke VP, Corporate Communications
Corporate.Communications@livanova.com
LivaNova (NASDAQ:LIVN)
Historical Stock Chart
From Apr 2024 to May 2024
LivaNova (NASDAQ:LIVN)
Historical Stock Chart
From May 2023 to May 2024